Skip to main content
FERMENTA BIOTECH LIMITED logo

FERMENTA BIOTECH LIMITED — Investor Relations & Filings

Ticker · FERMENTA ISIN · INE225B01021 LEI · 335800VNTNWW8G1U9314 BSE.NS Manufacturing
Filings indexed 671 across all filing types
Latest filing 2021-09-28 Regulatory Filings
Country IN India
Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing Released Lang Actions
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will ....
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchange about a scheduled conference call with analysts and institutional investors. It references SEBI regulations and states the purpose is to discuss an investor presentation. There is no actual financial data or detailed report content included, and the document length is only 1467 characters, indicating it is an announcement rather than a full report or transcript. It is not a transcript itself, nor a financial report, but an announcement of an upcoming event related to investor communication. Therefore, the most appropriate classification is 'Regulatory Filings' (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2021-09-28 English
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting ....
Regulatory Filings Classification · 95% confidence The document is a short notice informing about a scheduled conference call with analysts and institutional investors to discuss an investor presentation. It explicitly states the meeting date and that no unpublished price sensitive information will be discussed. The document references SEBI regulations and is an intimation of the schedule of the call, not the call transcript itself or the presentation content. The length is short (1848 characters), and it serves as an announcement of the event rather than the event content. Therefore, it fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement about an investor call schedule, not the call transcript (CT) or investor presentation (IP).
2021-09-22 English
Pursuant to Regulation 44 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the results of remote ....
Regulatory Filings
2021-09-03 English
Submission of voting results of Ballot process and Remote E-voting under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with the ....
Regulatory Filings
2021-09-03 English
In terms of Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby furnish the proceedings at the 69th ....
AGM Information Classification · 100% confidence The document is a detailed summary of the proceedings at the 69th Annual General Meeting (AGM) of Fermenta Biotech Limited held on September 3, 2021. It includes information about the meeting format (video conferencing), attendance, agenda items discussed, voting procedures, and resolutions passed. The document references the Annual Report for the financial year ended March 31, 2021, but does not contain the report itself. Instead, it provides a narrative of the AGM proceedings, which is typical for filings categorized as AGM Information. The document is over 10,000 characters, indicating it is not a brief announcement but a substantive summary of the AGM. Therefore, the appropriate classification is AGM Information (AGM-R).
2021-09-03 English
Pursuant to the provisions of Regulation 30 of Listing Regulations, we hereby inform that the members of the Company at the 69th Annual General Meeting held today ('AGM'), have approved: ....
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to the stock exchange (BSE Limited) referencing Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It reports the outcomes of the 69th Annual General Meeting (AGM) held on the same day, specifically the approval of appointments and re-appointments of directors and senior management positions. The content includes detailed information about the directors appointed or re-appointed, their terms, and affirmations related to their eligibility. There is no financial data or report attached, nor is this a transcript or presentation. The document is clearly an announcement of board/management changes following the AGM. Therefore, the appropriate classification is Board/Management Information (MANG). The document length and detail support a high confidence in this classification.
2021-09-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.